| Literature DB >> 34531681 |
Ramana K Naidu1, Rahul Chaturvedi2, Alyson M Engle3, Pankaj Mehta4, Brian Su1, Krishnan Chakravarthy5, Kasra Amirdelfan6, Jeffrey Henn7, Dawood Sayed8, Jay Grider9, Timothy Deer3.
Abstract
BACKGROUND: The discipline of interventional pain management has changed significantly over the past decade with an expected greater evolution in the next decade. Not only have the number of procedures increased, some of the procedures that were created for spine surgeons are becoming more facile in the hands of the interventional pain physician. Such change has outpaced academic institutions, societies, and boards. When a pain physician is in the credentialing process for novel procedure privileges, it can leave the healthcare system in a challenging situation with little to base their decision upon.Entities:
Keywords: credentialing; guidelines; interventional pain management; interventional spine care
Year: 2021 PMID: 34531681 PMCID: PMC8439288 DOI: 10.2147/JPR.S309705
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Standard Objective Criteria Used in Considering Healthcare Providers for a Medical Staff Appointment6
| • Graduation from a liaison committee on medical education-accredited allopathic medical school, colleges of osteopathy, or recognized international medical schools |
| • Completion of an Accreditation Council for Graduate Medical Education (ACGME) or osteopathic-approved residency training program |
| • Licensure to practice medicine in the respective state |
| • Review of National Practitioner Data Bank reports of adverse events |
| • License to administer controlled substances at the national and state levels |
| • Certification by a member board of the American Board of Anesthesiology, American Academy of Pain Medicine, American Board of Pain Medicine, or an American Board of Medical Specialties |
| • Verification of past performance (including review of adverse professional actions or terminations from all previous practice locations) |
| • Verification of any previous or ongoing liability claims and their outcomes |
| • Verification of medical liability insurance coverage |
| • A suitable practice/clinic environment to see patients |
| • Willingness to comply with institutional practice policies |
| • Verification of professional qualities, training, and experience, with confirmation from previous training directors and locations of practice |
| • Verification that the physician is free of any physical, mental, and cognitive impairment that would preclude the safe practice of surgery (including drug and alcohol dependence, disruptive conduct, and the adverse effects of aging) |
| • Comprehensive review of peer recommendations may be part of the assessment prior to credentialing. |
Recommended Guidelines for Incorporating Advanced Procedures into the Standard Objective Criteria for Credentialing and Privileging
| • Graduation from a liaison committee on medical education-accredited allopathic medical school, colleges of osteopathy, or recognized international medical schools |
| • Completion of an Accreditation Council for Graduate Medical Education (ACGME) or osteopathic-approved residency training program |
| • Licensure to practice medicine in the respective state |
| • Review of National Practitioner Data Bank reports of adverse events |
| • License to administer controlled substances at the national and state levels |
| • Certification by a member board of the American Board of Anesthesiology, American Academy of Pain Medicine, American Board of Pain Medicine, or an American Board of Medical Specialties |
| • Verification of past performance (including review of adverse professional actions or terminations from all previous practice locations) |
| • Verification of any previous or ongoing liability claims and their outcomes |
| • Verification of medical liability insurance coverage |
| • A suitable practice/clinic environment to see patients |
| • Willingness to comply with institutional practice policies |
| • Verification of professional qualities, training, and experience, with confirmation from previous training directors and locations of practice |
| • Verification that the physician is free of any physical, mental, and cognitive impairment that would preclude the safe practice of surgery (including drug and alcohol dependence, disruptive conduct, and the adverse effects of aging) |
| • Comprehensive review of experienced provider recommendations for each advanced procedure |
| • Case logs from residency, fellowship, and proctored cases |
| • Focused professional practice evaluations on requested cases |
| • Patient outcomes following interventions during the provisional period, including multidimensional benchmarks (eg patient satisfaction, adverse effects, safety profile, efficacy of therapy, et cetera). |
ASPN Hospital Delineation of Pain Privileges
| Pain Management | Constitutes a medical trans-disciplinary specialty with five modalities including interventional, pharmacologic, complementary and integrative, rehabilitation, and psychological that provides care for adult and pediatric patients who are suffering from an unpleasant sensory or emotional experience. | ||
| Interventional Pain Management (IPM) | Is a procedural sub-specialty that requires an understanding of spinal and peripheral neuroanatomy, radiological safety, surgical safety, and the management of complications including neural injury. | ||
| Diagnosis and management of acute pain: medical, trauma and surgical; chronic pain; and cancer-related pain | Minimum of 3 cases | ||
| • Performance of focused pain-specific history and physical exam, eg PQRST | |||
| • Appropriate use of assessment tools (eg POSS, CPOT, Wong-Baker, SOAPP-R, ODI, PROMIS-29, etc.) and appropriate diagnostic tests are ordered and interpreted | |||
| • Recognition and management of misuse, abuse and addiction of controlled substances | |||
| • Recognition and management of therapies, side effects, and complications of pharmacologic agents used in the management of pain | |||
| • Expert-level knowledge regarding the use of opioid pharmacokinetics/pharmacodynamics, and the risk to the individual and society. | |||
| • Expert-level knowledge regarding the use of anesthetic infusions such as ketamine and lidocaine, pharmacokinetics/pharmacodynamics, and the risk to the individual. | |||
| • When to consult and refer to physical therapy, occupational therapy and rehabilitative services. | |||
| • When to consult with complementary and integrative services | |||
| • When to consult with Psychiatric Services | |||
| • Superficial electrical stimulation techniques (eg, transcutaneous electrical neural stimulation) | |||
| Myofascial/Trigger point injections | |||
| Experience | In addition to core pain management requirements above, for pain management level 2 procedures the practitioner must be able to supply evidence of having performed 50 of any level 2 procedures in the past two years. This may include post-graduate training case log. This evidence must also include at least 15 procedures within the individual Group requested. | ||
| Single shot peripheral regional anesthesia (eg femoral, saphenous, suprascapular, intercostal, occipital nerves) under imaging guidance (U/S or fluoroscopy) | Minimum of 3 cases of any Tier 2 Group 1 procedures | ||
| Single shot peripheral regional anesthesia (eg femoral, saphenous, suprascapular, intercostal, occipital nerves) under imaging guidance (U/S or fluoroscopy) | Minimum of 3 cases of any Tier 2 Group 1 procedures | ||
| Injection of MAJOR joints, including sacroiliac, hip, knee, shoulder, etc. | |||
| Injection of bursae, including greater trochanteric bursa, ischial tuberosity bursa, etc. | |||
| Radiofrequency ablation (RFA)/Rhizotomy/Neurolysis and the Diagnostic Blockade of articulating branches for major joints including sacroiliac joint, shoulder, hip, and knee (evidence of 3 prior cases required)* | |||
| Chemical motor denervation (eg Botox® injection) | |||
| Insertion of indwelling catheters for the use of regional anesthesia (epidural, continuous spinal, peripheral neural blockade) | Minimum of 3 cases of any Tier 2 Group 2 procedures | ||
| Epidural Steroid Injection (interlaminar and/or transforaminal) under fluoroscopic guidance | |||
| Epidural adhesiolysis | |||
| Facet (zygapophyseal joint) injection under fluoroscopic guidance (C/T/L/S) | |||
| Radiofrequency ablation (RFA)/Rhizotomy/Neurolysis and the Diagnostic Blockade of spinal medial branches (C/T/L) (evidence of 3 prior cases required) | |||
| Intradiscal injection (eg local anesthetics, therapeutics) | |||
| Provocation discography | |||
| Sympathetic Blockade: (Stellate Ganglion, Celiac Plexus/Retrocrural Splanchnic, Superior Hypogastric, Ganglion Impar) | |||
| Experience | In addition to core pain management requirements above, for pain management level 3 procedures the practitioner must be able to supply evidence of having performed 5 of any level 3 procedures in the past two years. | ||
| Spinal Cord (Dorsal Column) Stimulation – percutaneous trial lead placement* | Minimum of 3 cases of any level 3 procedures | ||
| Dorsal Root Ganglion Stimulation – percutaneous trial lead placement. *(Must have completed FDA-mandated training) | |||
| Spinal Cord (Dorsal Column or Dorsal Root Ganglion) Stimulation – implantation and explantation of leads and implantable pulse generator* | |||
| Peripheral Nerve Stimulation – percutaneous trial lead placement, implantation, and explantation of implantable pulse generator* | |||
| Percutaneous Peripheral Nerve Stimulation with an External Pulse Generator (e.g SPR Therapeutics)* | |||
| Sympathetic Neurolysis: (Stellate Ganglion, Celiac Plexus/Retrocrural Splanchnic, Superior Hypogastric, Ganglion Impar) via chemical or thermal means. | |||
| Neuraxial Neurolysis including Subarachnoid | |||
| Kyphoplasty/Vertebroplasty* | |||
| Basivertebral Nerve Radiofrequency Ablation (eg Relievant Intracept)* | |||
| Intrathecal Pumps – percutaneous intrathecal catheter trial placement and management, implantation and explantation of intrathecal catheter and infusion pump* | |||
| Percutaneous discectomy/nucleoplasty | |||
| Indirect Lumbar Decompression of the Spine (eg Vertiflex Superion)* | |||
| Posterior Sacroiliac Joint Arthrodesis when implant is placed intra articular and parallel to the joint without additional fixation (ie no screw/rod construct across the joint)* | |||
| Direct Percutaneous Lumbar Decompression of the Spine (eg Vertos MILD)* | |||
Note: *May have prerequisite industry-led training.
Best Practice Guidelines for Industry Training of Novel Pain Procedures
| -Follow FDA-Directed Mandates on Procedural Training and Education. |
| -Training Course is directed by a Physician with Expertise in the Procedure. |
| -Trainees are peer selected by physicians, not solely by industry representatives. |
| -Train those with appropriate board certification and ACGME accredited training. |
| -Trainees are vetted for being in current satisfactory practice standing. |
| -Training be composed of didactic component that includes review of data, mechanisms, safety, and alternative treatments. |
| -Include Physician Directed Hands-on component with cadaver or equivalent models. |
| -Trainees should pass post exam assessment of clinical knowledge and hands-on component. |
| -Trainees with deficiencies should be identified for follow-up training opportunities prior to implementing procedure/therapy. |
Figure 1Flow chart.